A folate-targeted PEGylated cyclodextrin-based nanoformulation achieves co-delivery of docetaxel and siRNA for colorectal cancer
Yifang Zou, Fang Xiao, Liu Song, Bingxue Sun, Dandan Sun, Di Chu, Limei Wang, Shulan Han, Zhuo Yu, Caitríona M. O’Driscoll, Jianfeng Guo
Topics & Concepts
DocetaxelFolate receptorPharmacologyChemistryCancer researchCancerColorectal cancerCancer cellMedicineInternal medicineRNA Interference and Gene DeliveryNF-κB Signaling PathwaysCancer Research and Treatments